Eli Lilly Adds $375M to Zymeworks Partnership

Eli Lilly and Zymeworks said Wednesday they are expanding a cancer drug development partnership.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.